Optimum Management of Overactive Bladder: Medication vs Botox^® vs InterStim^® vs Urgent^® PC

Area of Science:

• Urology
• Pharmacology

Background:

• Overactive bladder (OAB) management is evolving, necessitating advanced therapeutic options.
• Anticholinergic medications are frequently used but often fail or cause intolerable side effects.

Purpose of the Study:

• To review approved therapies for overactive bladder (OAB) after failure of behavioral therapy and anticholinergic medications.
• To propose a new treatment paradigm to discontinue anticholinergic cycling.

Main Methods:

• Literature review of approved OAB therapies.
• Analysis of treatment failure rates associated with anticholinergic use.

Main Results:

• Anticholinergic medications demonstrate a high treatment failure rate, even with polypharmacy.
• A significant proportion of patients do not achieve symptom relief with current anticholinergic approaches.

Conclusions:

• Discontinuing the cycle of anticholinergic use is crucial for effective OAB management.
• Alternative treatments are essential to optimize therapy for patients with refractory overactive bladder.